Haemonetics ROE 2006-2018 | HAE

Current and historical return on equity (ROE) values for Haemonetics (HAE) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Haemonetics ROE for the three months ending December 31, 2018 was 17.05%.
Haemonetics ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2018-12-31 $0.05B $0.64B 6.64%
2018-09-30 $0.02B $0.70B 2.85%
2018-06-30 $0.02B $0.67B 2.89%
2018-03-31 $0.05B $0.75B 5.72%
2017-12-31 $-0.02B $0.82B -2.30%
2017-09-30 $0.00B $0.80B 0.52%
2017-06-30 $0.00B $0.77B 0.53%
2017-03-31 $-0.03B $0.74B -3.49%
2016-12-31 $0.02B $0.77B 2.16%
2016-09-30 $-0.06B $0.75B -7.98%
2016-06-30 $-0.07B $0.72B -8.86%
2016-03-31 $-0.06B $0.72B -7.31%
2015-12-31 $-0.05B $0.72B -6.29%
2015-09-30 $0.03B $0.78B 3.22%
2015-06-30 $0.02B $0.79B 2.44%
2015-03-31 $0.02B $0.83B 1.94%
2014-12-31 $0.03B $0.83B 3.51%
2014-09-30 $0.03B $0.82B 3.52%
2014-06-30 $0.04B $0.82B 4.76%
2014-03-31 $0.04B $0.84B 4.33%
2013-12-31 $0.04B $0.83B 4.80%
2013-09-30 $0.03B $0.80B 4.11%
2013-06-30 $0.02B $0.77B 2.84%
2013-03-31 $0.04B $0.77B 5.20%
2012-12-31 $0.05B $0.78B 5.92%
2012-09-30 $0.05B $0.77B 7.15%
2012-06-30 $0.06B $0.76B 8.35%
2012-03-31 $0.07B $0.73B 9.48%
2011-12-31 $0.07B $0.71B 10.07%
2011-09-30 $0.07B $0.68B 10.57%
2011-06-30 $0.08B $0.71B 11.97%
2011-03-31 $0.08B $0.69B 12.83%
2010-12-31 $0.06B $0.65B 10.50%
2010-09-30 $0.06B $0.59B 10.49%
2010-06-30 $0.06B $0.57B 10.04%
2010-03-31 $0.06B $0.59B 10.05%
2009-12-31 $0.07B $0.57B 12.06%
2009-09-30 $0.07B $0.58B 12.01%
2009-06-30 $0.06B $0.56B 11.90%
2009-03-31 $0.06B $0.54B 11.53%
2008-12-31 $0.06B $0.52B 11.79%
2008-09-30 $0.06B $0.50B 11.64%
2008-06-30 $0.05B $0.49B 11.10%
2008-03-31 $0.05B $0.49B 10.99%
2007-12-31 $0.06B $0.47B 12.35%
2007-09-30 $0.06B $0.45B 13.13%
2007-06-30 $0.05B $0.48B 10.93%
2007-03-31 $0.05B $0.48B 10.58%
2006-12-31 $0.05B $0.45B 10.15%
2006-09-30 $0.06B $0.46B 12.82%
2006-06-30 $0.07B $0.46B 15.68%
2006-03-31 $0.07B $0.44B 17.04%
2005-12-31 $0.06B $0.42B 16.17%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $4.311B $0.904B
Haemonetics Corporation is a Global Leader in Blood Management Solutions. Their comprehensive portfolio of devices, information management, consulting services offers blood management solutions for each facet of the blood supply chain from plasma blood collectors to hospitals. They believe that through proper blood management, their portfolio of products and services helps to prevent a transfusion for the patient who doesn't need one and provides the right blood product, at the right time, in the right dose to the right patient who does.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $136.952B 27.07
Medtronic (MDT) Ireland $121.227B 17.72
Stryker (SYK) United States $72.547B 26.60
Boston Scientific (BSX) United States $51.696B 25.20
Baxter (BAX) United States $39.588B 25.33
Zimmer Biomet Holdings (ZBH) United States $25.898B 16.58
Smith & Nephew SNATS (SNN) United Kingdom $17.446B 0.00
Canopy Growth (CGC) Canada $14.852B 0.00
ResMed (RMD) United States $14.350B 27.21
Bio-Rad Laboratories (BIO) United States $9.156B 52.24
Aurora Cannabis (ACB) Canada $9.141B 64.50
Hill-Rom Holdings (HRC) United States $6.962B 21.53
Perrigo (PRGO) Ireland $6.420B 10.41
Insulet (PODD) United States $5.800B 1956.80
GW Pharmaceuticals (GWPH) United Kingdom $5.092B 0.00
ICU Medical (ICUI) United States $4.698B 29.24
Hutchison China MediTech (HCM) China $3.810B 0.00
Agios Pharmaceuticals (AGIO) United States $3.637B 0.00
Neogen (NEOG) United States $3.108B 47.74
NuVasive (NUVA) United States $2.892B 25.23
Quidel (QDEL) United States $2.514B 22.68
Aphria (APHA) $2.385B 105.89
National Vision Holdings (EYE) United States $2.274B 44.72
Cardiovascular Systems (CSII) United States $1.346B 966.50
Phibro Animal Health (PAHC) United States $1.283B 18.45
VAREX IMAGING (VREX) United States $1.275B 24.96
AtriCure (ATRC) United States $1.081B 0.00
MacroGenics (MGNX) United States $0.926B 0.00
Lantheus Holdings (LNTH) United States $0.911B 24.60
Cerus (CERS) United States $0.844B 0.00
PetIQ (PETQ) United States $0.831B 23.77
Omeros (OMER) United States $0.828B 0.00
NanoString Technologies (NSTG) United States $0.729B 0.00
Meridian Bioscience (VIVO) United States $0.715B 21.30
OraSure Technologies (OSUR) United States $0.664B 29.11
Eagle Pharmaceuticals (EGRX) United States $0.657B 22.35
Evolus (EOLS) United States $0.655B 0.00
TG Therapeutics (TGTX) United States $0.601B 0.00
LeMaitre Vascular (LMAT) United States $0.596B 28.35
Surmodics (SRDX) United States $0.563B 81.90
Quanterix (QTRX) United States $0.518B 0.00
BioLife Solutions (BLFS) United States $0.364B 150.23
Vapotherm (VAPO) United States $0.335B 0.00
Rockwell Medical (RMTI) United States $0.331B 0.00
Insys Therapeutics (INSY) United States $0.328B 0.00
Utah Medical Products (UTMD) United States $0.300B 19.49
Owens & Minor (OMI) United States $0.271B 3.76
Bovie Medical (APYX) United States $0.260B 0.00
Cytosorbents (CTSO) United States $0.241B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.238B 0.00
Zynex (ZYXI) United States $0.145B 15.52
Fonar (FONR) United States $0.137B 7.33
Surface Oncology (SURF) United States $0.116B 0.00
Chimerix (CMRX) United States $0.102B 0.00
Female Health (VERU) United States $0.100B 0.00
Chembio Diagnostics (CEMI) United States $0.096B 0.00
United-Guardian (UG) United States $0.087B 19.84
CAS Medical Systems (CASM) United States $0.072B 0.00
Neurotrope (NTRP) United States $0.065B 0.00
Trinity Biotech (TRIB) Ireland $0.058B 17.14
Oramed Pharmaceuticals (ORMP) United States $0.056B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.039B 0.00
ImmuCell (ICCC) United States $0.038B 0.00
Valeritas Holdings (VLRX) United States $0.035B 0.00
Senestech (SNES) United States $0.029B 0.00
Capricor Therapeutics (CAPR) United States $0.018B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.016B 0.00
Akers Biosciences Inc (AKER) United States $0.013B 0.00
Cellectar Biosciences (CLRB) United States $0.011B 0.00
NeuroMetrix (NURO) United States $0.008B 15.29